are immunosuppressants biological products
As a result of Public Act 097-0689 ( pdf ) , referred to as the Save Medicaid Access and Resources Together ( SMART ) Act , the department must develop utilization controls , including prior approval , for specialty drugs , oncolytic drugs , drugs for the treatment of HIV or AIDS , immunosuppressant drugs , and biological products in order to ...